Status:
UNKNOWN
Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System
Lead Sponsor:
Fundación Pública Andaluza Progreso y Salud
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
Brief Summary
STUDY OF USE OF PEMETREXED IN PATIENTS WITH NON-SMALL LUNG CANCER METASTATIC IN ANDALUSIAN PUBLIC HEALTH SYSTEM
Eligibility Criteria
Inclusion
- Patients over 18 years
- Confirmed diagnosis of metastatic NSCLC
- Pemetrexed Starts 1st line (either induction or maintenance) in any of the following periods:
- January 1, 2010 to March 31, 2010
- October 1, 2011 to December 31, 2011
Exclusion
- Patients receiving pemetrexed within a clinical trial protocol because it is an experimental environment that does not reflect clinical practice.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT01877902
Start Date
October 1 2011
Last Update
December 5 2014
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital La Línea
Algeciras, Cádiz, Spain
2
Hospital Punta de Europa
Algeciras, Cádiz, Spain
3
Hospital Jerez de la Frontera
Jerez de la Frontera, Cádiz, Spain
4
Hospital Costa del Sol
Marbella, Cádiz, Spain